United States · Seed startup

Who invested in TriVirum

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Funding summaryUpdated 26 Oct 2026

$9.1Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $9.1MJun 2023
Investors
1
See who backed them

The rounds

  1. Jun 2023
    Seed$9.1M

    Source recordedSEC filing: $3.1M sold, first sale May 2023

Founders and team

From the SEC filings it signed: 2 on the team.

  • Bill WillisExecutive Officer, Director, Promoteri
  • Yasmin SeyalExecutive Officeri

On the board, as filediChristian RenaudinJustin BellanteKenneth BuechlerRobert Higginson

Everyone who backed them

Par EquityVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists TriVirum as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Particular VenturesAngel networkPer its own site

Quick answers about TriVirum

Who invested in TriVirum?

TriVirum's investors include Par Equity.

How much has TriVirum raised?

TriVirum has raised $9.1M across 1 round since 2023.

When did TriVirum last raise?

TriVirum's most recent round was a Seed of $9.1M in Jun 2023.

What was TriVirum's biggest round?

Its most recent round, $9.1M in Jun 2023, is also its largest on record.

Who backed TriVirum first?

TriVirum's first round on record, in Jun 2023, was backed by Par Equity.

What stage is TriVirum at?

TriVirum's latest named round is a Seed, in Jun 2023.

Where is TriVirum based?

TriVirum is based in the United States.

Companies like TriVirum

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.